Evidence — Epitalon
peptide · asset evidence level: theoretical
Evidence quality breakdown (linked documents)
expert_opinion: 11preclinical: 1
Linked source documents (12)
- SS-31 — Peptide Dosing Protocols reference (patient_education · expert_opinion)
- Semax — Peptide Dosing Protocols reference (patient_education · expert_opinion)
- GHK-Cu — Peptide Dosing Protocols reference (patient_education · expert_opinion)
- Epitalon — Peptide Dosing Protocols reference (patient_education · expert_opinion)
- DSIP — Peptide Dosing Protocols reference (patient_education · expert_opinion)
- SNAP-8 — Peptide Protocol Wiki reference (patient_education · expert_opinion)
- NAD+ — Peptide Protocol Wiki reference (patient_education · expert_opinion)
- SS-31 — Peptide Protocol Wiki reference (patient_education · expert_opinion)
- GHK-Cu — Peptide Protocol Wiki reference (patient_education · expert_opinion)
- Epitalon — Peptide Protocol Wiki reference (patient_education · expert_opinion)
- Endoluten: Tissue-Targeted Bioregulator (Pineal) (internal_protocol · expert_opinion)
- Epitalon: Mechanistic Overview (internal_protocol · preclinical)
Provider dosing references (Stage 9, source-attributed)
5-10 mg per day — Peptide Protocol Wiki (peptideprotocolwiki.com)
Standard: 5 mg/day · High: 10 mg/day — Peptide Dosing Protocols (peptidedosingprotocols.com)
Dosing claims (67) · Safety claims (32)
Extracted claims are provider-review scaffolding, stored verbatim with source attribution — not recommendations or dosing guidance.